John S. Kovach's most recent trade in Lixte Biotechnology Holdings Inc was a trade of 200,000 Stock Options done . Disclosure was reported to the exchange on Nov. 6, 2022.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Lixte Biotechnology Holdin... | John S. Kovach | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Nov 2022 | 200,000 | 200,000 | - | - | Stock Options | |
Lixte Biotechnology Holdin... | John S. Kovach | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.75 per share. | 30 Nov 2020 | 21,100 | 1,540,183 | - | 4.8 | 100,225 | Common Stock |
Lixte Biotechnology Holdin... | John S. Kovach | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 30 Nov 2020 | 21,100 | 21,100 | - | - | Warrants to Purchase Common Stock |